Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

(Cell 175, 998–1013.e1–e20; November 1, 2018) In the originally published version of this article, the text associated with the vertical axis in Figure 6E mistakenly referred to the CD39−TIM3−/ CD39+TIM3+ ratio, but the values correspond to the inverse ratio, i.e., CD39+TIM3+/CD39−TIM3−. The corrected Figure 6E is shown here, and this error has now been corrected in the article online. The authors apologize for any confusion this error may have caused.Figure 6EDifferential Chromatin Accessibility in CD39+TIM3+ and CD39−TIM3− cells (original)View Large Image Figure ViewerDownload Hi-res image Download (PPT) Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaSade-Feldman et al.CellNovember 01, 2018In BriefSingle-cell analysis of immune cells from melanoma patients treated with immune checkpoint therapy uncovers a TCF7+ memory-like state in the cytotoxic T cell population and demonstrates its association with a positive outcome. Full-Text PDF Open Archive